Michael Aaron Kelly - Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APRE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Aaron Kelly since 12/22/2023

Holdings reported by Michael Aaron Kelly for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.61K $17K $3.68 Jun 30, 2021 Direct
Stock Option (Right to Buy) 22.8K Jun 30, 2021 Direct Common Stock

Transactions reported by Michael Aaron Kelly for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.